What it is
Increased tolerance describes the need for progressively larger amounts of a substance or behaviour to achieve the same effect, a defining feature of physical and psychological dependence.
A need for increasing quantities of a substance or intensity of a behaviour to achieve the same effect — a core marker of dependence and addiction.

At a glance
What it is
Increased tolerance describes the need for progressively larger amounts of a substance or behaviour to achieve the same effect, a defining feature of physical and psychological dependence.
Commonly experienced as
Evidence context
Research-supportedSee the evidence snapshotSafety
See staying safeContext
Tolerance is a neuroadaptive process in which repeated exposure to a substance or behaviour results in diminishing response — requiring escalating doses or intensities to achieve the same effect. It is one of the core criteria for substance use disorder (alongside loss of control, withdrawal, and continued use despite consequences) and occurs in the context of alcohol, opioids, benzodiazepines, stimulants, cannabis, nicotine, and behavioural addictions (gambling, gaming, sex). Physiologically, tolerance reflects receptor downregulation, altered neurotransmitter systems, and metabolic enzyme induction. Cross-tolerance (tolerance to one substance extending to another within the same class) is clinically important, particularly in opioid and benzodiazepine management. The presence of tolerance should prompt clinical assessment for dependence.
The Evidence
What the evidence says about tolerance, dependence, and the clinical and complementary approaches used in addiction medicine.
Tolerance is a well-understood neuroadaptive process with serious clinical implications
Tolerance reflects measurable changes in brain receptor systems and is a core criterion for substance use disorder. Evidence-based interventions exist across medical, psychological, and harm reduction approaches, but some withdrawal states carry life-threatening risk requiring professional oversight.
Tolerance to alcohol, benzodiazepines, or opioids with physical dependence carries serious withdrawal risk — including seizures and respiratory depression. Abrupt cessation without medical supervision is dangerous. Escalating doses with significant health, social, or occupational consequences warrant urgent professional assessment, not self-managed reduction.
The neurobiology of tolerance — receptor downregulation, neurotransmitter adaptation, enzyme induction — is well established. Pharmacological interventions including opioid substitution therapy, naltrexone, and nicotine replacement therapy carry strong evidence. Psychological approaches such as CBT and motivational interviewing are also well-supported across substance types.
Where physical dependence is present, medically supervised withdrawal management is a recommended starting point. Harm reduction — reducing escalation without requiring abstinence — is evidence-based for many substances. Cross-tolerance within drug classes (e.g. opioids, benzodiazepines) is clinically important and must be factored into any prescribing or tapering plan.
The NADA auricular acupuncture protocol is used in addiction programmes internationally, with some supporting evidence for reducing cravings and supporting engagement. Mindfulness-based approaches, including urge surfing techniques, show emerging evidence for helping seekers recognise and pause cue-triggered impulses toward dose escalation — a mechanism directly relevant to tolerance progression. These are adjuncts to, not substitutes for, evidence-based addiction medicine.
If you or someone you know is noticing that more of a substance is needed to achieve the same effect, this is a signal to seek professional assessment early. Tolerance progression is a measurable indicator that dependence thresholds may be approaching — making it a particularly actionable moment for assessment before physical dependence becomes established. Addiction medicine specialists, GPs, and substance use services can assess risk and offer structured support.
This content explains tolerance as a neurological and clinical phenomenon. It does not constitute professional assessment, and no content on this platform should be used to self-manage withdrawal from alcohol, opioids, or benzodiazepines. If you are concerned about your own or someone else's substance use, please contact a qualified health professional or addiction service.
Safety first
General, informational guidance — not diagnostic. A qualified practitioner can advise on your own situation.
Featured
These practitioners have chosen to be featured on Gyfts.
Top Practitioners
Practitioners are ranked using relevance, experience signals, reviews, and support-area fit.
References
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Browse verified practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.